Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
623K
-
Shares change
-
-50.7K
-
Total reported value, excl. options
-
$219M
-
Value change
-
-$17.8M
-
Number of buys
-
2
-
Number of sells
-
-4
-
Price
-
$352.12
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2023
8 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q4 2023.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 623K shares
of 71.9M outstanding shares and own 0.87% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9M shares), BlackRock Inc. (7.78M shares), Bank of New York Mellon Corp (3.33M shares), STATE STREET CORP (3.27M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.33M shares), APG Asset Management N.V. (2.3M shares), FRANKLIN RESOURCES INC (2.11M shares), Artisan Partners Limited Partnership (1.96M shares), GEODE CAPITAL MANAGEMENT, LLC (1.67M shares), and BROWN ADVISORY INC (1.41M shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.